Next FDA Commissioner May See Funding Freeze
This article was originally published in The Pink Sheet Daily
Hamburg gets warm farewell at appropriations hearing, but House subcommittee chair says FY 2016 funding likely will be flat at best.
You may also be interested in...
Only a handful of new FTEs are requested in President Obama’s FY 2016 budget request for human drugs activities, suggesting that GDUFA and other related programs may have reached their critical mass of employees for now.
President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.
The request for an interview by the House Select Subcommittee on the Coronavirus Crisis seeks more information on the actions by President Trump and others to influence FDA decisions on HCQ, convalescent plasma, and vaccine decisions.